Introduction
Gonorrhea - Overview
Gonorrhea - Therapeutics Development
Gonorrhea - Therapeutics Assessment
Gonorrhea - Companies Involved in Therapeutics Development
Gonorrhea - Drug Profiles
Gonorrhea - Dormant Projects
Gonorrhea - Discontinued Products
Gonorrhea - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Gonorrhea, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Gonorrhea - Pipeline by Biolytics Pharma, 2021
Gonorrhea - Pipeline by Boulos and Cooper Pharmaceuticals Pty Ltd, 2021
Gonorrhea - Pipeline by Nabriva Therapeutics Plc, 2021
Gonorrhea - Pipeline by Paratek Pharmaceuticals Inc, 2021
Gonorrhea - Pipeline by Pharmiva AB, 2021
Gonorrhea - Pipeline by Redx Pharma Plc, 2021
Gonorrhea - Pipeline by TherapyX Inc, 2021
Gonorrhea - Pipeline by Yaso Therapeutics Inc, 2021
Gonorrhea - Dormant Projects, 2021
Gonorrhea - Discontinued Products, 2021

List of Figures
Number of Products under Development for Gonorrhea, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• Biolytics Pharma
• Boulos and Cooper Pharmaceuticals Pty Ltd
• Debiopharm International SA
• Entasis Therapeutics Holdings Inc
• GlaxoSmithKline Plc
• Hsiri Therapeutics LLC
• Melinta Therapeutics Inc
• Merck & Co Inc
• Microbiotix Inc